tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

AstraZeneca: Expanding COPD Biologic Opportunity With Tozorakimab Underpins Buy Rating and Long‑Term Growth Upside
RatingsAstraZeneca: Expanding COPD Biologic Opportunity With Tozorakimab Underpins Buy Rating and Long‑Term Growth Upside
1d ago
AZN
AstraZeneca price target raised to 18,000 GBp from 17,000 GBp at Citi
PremiumThe Fly
AstraZeneca price target raised to 18,000 GBp from 17,000 GBp at Citi
4d ago
AZN
AstraZeneca Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany Announcements
AstraZeneca Wins Strong Shareholder Backing at 2026 AGM
5d ago
AZN
AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study
PremiumCompany Announcements
AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study
6d ago
AZN
AstraZeneca price target raised to 16,500 GBp from 16,000 GBp at Morgan Stanley
PremiumThe Fly
AstraZeneca price target raised to 16,500 GBp from 16,000 GBp at Morgan Stanley
6d ago
AZN
AstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating
PremiumRatingsAstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating
7d ago
AZN
AstraZeneca price target raised to 16,500 GBp from 16,000 GBp at Morgan Stanley
Premium
The Fly
AstraZeneca price target raised to 16,500 GBp from 16,000 GBp at Morgan Stanley
7d ago
AZN
Compugen initiated with a Buy at Lake Street
Premium
The Fly
Compugen initiated with a Buy at Lake Street
7d ago
AZN
MRK
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
PremiumThe Fly
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
8d ago
AA
CI
White House says imposing tariffs on patented pharmaceutical products
PremiumThe Fly
White House says imposing tariffs on patented pharmaceutical products
12d ago
AZN
BMY
AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates
PremiumCompany Announcements
AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates
12d ago
AZN
Trump Trade: President says Iran war will still take weeks
PremiumThe Fly
Trump Trade: President says Iran war will still take weeks
12d ago
AA
MT
AstraZeneca Phase III EMERALD-3 trial showed meaningful improvement in endpoint
PremiumThe FlyAstraZeneca Phase III EMERALD-3 trial showed meaningful improvement in endpoint
12d ago
AZN
Trump administration readying new pharmaceutical tariffs, FT reports
Premium
The Fly
Trump administration readying new pharmaceutical tariffs, FT reports
12d ago
AZN
BMY
AstraZeneca U.S. shares assumed with Buy at Goldman Sachs
Premium
The Fly
AstraZeneca U.S. shares assumed with Buy at Goldman Sachs
12d ago
AZN
AstraZeneca Reports Strong Liver Cancer Results for Imfinzi–Imjudo Combo in EMERALD-3 Trial
PremiumCompany Announcements
AstraZeneca Reports Strong Liver Cancer Results for Imfinzi–Imjudo Combo in EMERALD-3 Trial
12d ago
AZN
AstraZeneca Updates Total Voting Rights and Admits Additional Shares for Employee Schemes
PremiumCompany Announcements
AstraZeneca Updates Total Voting Rights and Admits Additional Shares for Employee Schemes
13d ago
AZN
AstraZeneca: Buy Rating on Near‑Term Execution Strength and Undemanding Valuation Ahead of Pipeline‑Driven Re‑Rating
PremiumRatings
AstraZeneca: Buy Rating on Near‑Term Execution Strength and Undemanding Valuation Ahead of Pipeline‑Driven Re‑Rating
13d ago
AZN
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
PremiumThe Fly
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
14d ago
AZN
BMY
AstraZeneca announces results of 3 trials of efzimfotase alfa
PremiumThe FlyAstraZeneca announces results of 3 trials of efzimfotase alfa
14d ago
AZN
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
Premium
The Fly
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
14d ago
AZN
BMY
AstraZeneca’s rare disease unit posts positive Phase III data for new hypophosphatasia therapy
Premium
Company Announcements
AstraZeneca’s rare disease unit posts positive Phase III data for new hypophosphatasia therapy
14d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >